Status:
COMPLETED
Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Minnesota HealthSolutions
Conditions:
Obstructive Sleep Apnea
Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to develop a data driven system for persons with severe obesity sleep apnea that utilizes remote monitoring with health coaching to create behavior changes aimed at improv...
Eligibility Criteria
Inclusion
- Adult patients, 18 years of age or older.
- Diagnosis of Obstructive Sleep Apnea (OSA) and obesity (BMI \> or = to 35).
Exclusion
- Individuals \< 18 years of age.
- Patients with an inability to provide good data or follow commands (patients who are disoriented, have a severe neurologic or psychiatric condition).
Key Trial Info
Start Date :
February 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 25 2024
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT05343000
Start Date
February 3 2024
End Date
September 25 2024
Last Update
October 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905